Cara Therapeutics
CARA
#10367
Rank
NZ$14.03 M
Marketcap
NZ$9.21
Share price
-2.56%
Change (1 day)
1,891.45%
Change (1 year)

Earnings for Cara Therapeutics (CARA)

Earnings in 2024 (TTM): -NZ$0.11 Billion

According to Cara Therapeutics 's latest financial reports the company's current earnings are NZ$7.13 Million. , an increase over its 2023 earnings that were of -NZ$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cara Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.11 Billion-45.49%
2023 -NZ$0.2 Billion31.6%
2022 -NZ$0.16 Billion-1.74%
2021 -NZ$0.16 Billion-1754.28%
2020 NZ$9.32 M-104.82%
2019 -NZ$0.2 Billion44.32%
2018 -NZ$0.14 Billion30.09%
2017 -NZ$0.11 Billion1.86%
2016 -NZ$0.11 Billion131.86%
2015 -NZ$43.61 Million39.38%
2014 -NZ$31.29 Million9120.41%
2013 -NZ$0.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Trevena
TRVN
-NZ$53.76 Million-50.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-NZ$0.14 Billion 26.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
NZ$6.51 M-105.99%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-NZ$17.81 Million-83.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.51 B-18,975.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.07 B-51,692.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.48 Billion 332.81%๐Ÿ‡บ๐Ÿ‡ธ USA